Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
[Lenalidomide treatment in myelodysplastic syndrome with 5q deletion--Czech MDS group experience]. [electronic resource] by
- Jonášová, Anna
- Červinek, Libor
- Bělohlávková, Petra
- Čermák, Jaroslav
- Beličková, Monika
- Rohoň, Petr
- Černá, Olga
- Hochová, Ivana
- Šišková, Magda
- Kačmářová, Karla
- Janoušová, Eva
Producer: 20160324
In:
Vnitrni lekarstvi vol. 61
Availability: No items available.
|
|
8.
|
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment. [electronic resource] by
- Jaruskova, Monika
- Curik, Nikola
- Hercog, Rajna
- Polivkova, Vaclava
- Motlova, Eliska
- Benes, Vladimir
- Klamova, Hana
- Pecherkova, Pavla
- Belohlavkova, Petra
- Vrbacky, Filip
- Machova Polakova, Katerina
Producer: 20171218
In:
Journal of experimental & clinical cancer research : CR vol. 36
Availability: No items available.
|
|
9.
|
Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in [electronic resource] by
- Horňák, Tomáš
- Semerád, Lukáš
- Žáčková, Daniela
- Weinbergerová, Barbora
- Šustková, Zuzana
- Procházková, Jiřina
- Bělohlávková, Petra
- Stejskal, Lukáš
- Rohoň, Peter
- Faber, Edgar
- Žák, Pavel
- Mayer, Jiří
- Ráčil, Zdeněk
Producer: 20210427
In:
Leukemia & lymphoma vol. 61
Availability: No items available.
|
|
10.
|
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy. [electronic resource] by
- Racil, Zdenek
- Koritakova, Eva
- Sacha, Tomasz
- Klamova, Hana
- Belohlavkova, Petra
- Faber, Edgar
- Rea, Delphine
- Malaskova, Ludmila
- Prochazkova, Jirina
- Zackova, Daniela
- Voglova, Jaroslava
- Wącław, Joanna
- Cetkovsky, Petr
- Zak, Pavel
- Mayer, Jiri
Producer: 20190627
In:
American journal of hematology vol. 93
Availability: No items available.
|
|
11.
|
First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter. [electronic resource] by
- Belohlavkova, Petra
- Steinerova, Katerina
- Karas, Michal
- Skoumalova, Iva
- Rohon, Peter
- Indrak, Karel
- Voglova, Jaroslava
- Vrbacky, Filip
- Cmunt, Eduard
- Necasova, Tereza
- Kristkova, Zlatuse
- Trneny, Marek
- Zak, Pavel
- Papajik, Tomas
- Faber, Edgar
Producer: 20200521
In:
Leukemia research vol. 81
Availability: No items available.
|
|
12.
|
No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia. [electronic resource] by
- Racil, Zdenek
- Razga, Filip
- Klamova, Hana
- Voglova, Jaroslava
- Belohlavkova, Petra
- Malaskova, Ludmila
- Potesil, David
- Muzik, Jan
- Zackova, Daniela
- Polakova, Katerina Machova
- Zdrahal, Zbynek
- Malakova, Jana
- Suttnar, Jiri
- Dyr, Jan
- Mayer, Jiri
Producer: 20140930
In:
Hematological oncology vol. 32
Availability: No items available.
|
|
13.
|
Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and intermediate-1). [electronic resource] by
- Jonasova, Anna
- Cermak, Jaroslav
- Vondrakova, Jana
- Siskova, Magda
- Hochova, Ivana
- Kadlckova, Eva
- Cerna, Olga
- Sykora, Michal
- Vozobulova, Vera
- Seifertova, Nadezda
- Michalova, Kyra
- Zemanova, Zuzana
- Brezinova, Jana
- Belohlavkova, Petra
- Kostecka, Arnost
- Neuwirtova, Radana
Producer: 20130124
In:
Leukemia research vol. 36
Availability: No items available.
|